Drug therapy.
D000342:Affective Symptoms / Q000188:drug therapy; D000928:Antidepressive Agents / Q000009:adverse effects / Q000627:therapeutic use; D002090:Butyrophenones / Q000627:therapeutic use; D002188:Cannabis; D002986:Clinical Trials as Topic; D006801:Humans; D008094:Lithium / Q000627:therapeutic use; D008238:Lysergic Acid Diethylamide / Q000627:therapeutic use; D001523:Mental Disorders / Q000188:drug therapy*; D008691:Methadone / Q000627:therapeutic use; D009539:Nicotinic Acids / Q000627:therapeutic use; D010433:Pentylenetetrazole / Q000627:therapeutic use; D010640:Phenothiazines / Q000627:therapeutic use; D011600:Psychopharmacology; D012559:Schizophrenia / Q000188:drug therapy; D019966:Substance-Related Disorders; D013888:Thiothixene / Q000627:therapeutic use; D014268:Trifluoperazine / Q000009:adverse effects
D000928:Antidepressive Agents; D002090:Butyrophenones; D009539:Nicotinic Acids; D010640:Phenothiazines; D014268:Trifluoperazine; D013888:Thiothixene; D008238:Lysergic Acid Diethylamide; D008094:Lithium; D008691:Methadone; D010433:Pentylenetetrazole